UBS Group AG - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$18,8982,903
+24091.7%
0.00%
Q3 2022$0
-100.0%
12
-97.6%
0.00%
Q2 2022$2,0000.0%502
-2.1%
0.00%
Q1 2022$2,000
-99.6%
513
-99.3%
0.00%
Q4 2021$525,000
+283.2%
78,840
+474.2%
0.00%
Q3 2021$137,000
+2640.0%
13,730
+7745.7%
0.00%
Q2 2021$5,000
-96.8%
175
-95.1%
0.00%
Q1 2021$154,000
+3750.0%
3,539
+3705.4%
0.00%
Q4 2020$4,000930.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders